 | • レポートコード：MRC2-11QY04903 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、92ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は結核治療のグローバル市場について調査・分析したレポートです。種類別（活動性結核、潜在性結核）市場規模、用途別（病院、クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別結核治療の競争状況、市場シェア ・世界の結核治療市場：種類別市場規模 2015年-2020年（活動性結核、潜在性結核） ・世界の結核治療市場：種類別市場規模予測 2021年-2026年（活動性結核、潜在性結核） ・世界の結核治療市場：用途別市場規模 2015年-2020年（病院、クリニック） ・世界の結核治療市場：用途別市場規模予測 2021年-2026年（病院、クリニック） ・北米の結核治療市場分析：米国、カナダ ・ヨーロッパの結核治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの結核治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の結核治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの結核治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Bayer、Eli Lilly、Labatec Pharma、Macleods Pharmaceuticals、Mylan、Novatis、Otsuka、Patheon、Pfizer ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Tuberculosis Treatment Market
The global Tuberculosis Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Tuberculosis Treatment Scope and Market Size
Tuberculosis Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Bayer
Eli Lilly
Labatec Pharma
Macleods Pharmaceuticals
Mylan
Novatis
Otsuka
Patheon
Pfizer
Market segment by Type, the product can be split into
Active TB
Latent TB
Market segment by Application, split into
Hospital
Clinic
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Tuberculosis Treatment Revenue
1.4 Market by Type
1.4.1 Global Tuberculosis Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Active TB
1.4.3 Latent TB
1.5 Market by Application
1.5.1 Global Tuberculosis Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Tuberculosis Treatment Market Perspective (2015-2026)
2.2 Global Tuberculosis Treatment Growth Trends by Regions
2.2.1 Tuberculosis Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Tuberculosis Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Tuberculosis Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Tuberculosis Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Tuberculosis Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Tuberculosis Treatment Players by Market Size
3.1.1 Global Top Tuberculosis Treatment Players by Revenue (2015-2020)
3.1.2 Global Tuberculosis Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Tuberculosis Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Tuberculosis Treatment Market Concentration Ratio
3.2.1 Global Tuberculosis Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Tuberculosis Treatment Revenue in 2019
3.3 Tuberculosis Treatment Key Players Head office and Area Served
3.4 Key Players Tuberculosis Treatment Product Solution and Service
3.5 Date of Enter into Tuberculosis Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Tuberculosis Treatment Historic Market Size by Type (2015-2020)
4.2 Global Tuberculosis Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Tuberculosis Treatment Market Size by Application (2015-2020)
5.2 Global Tuberculosis Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Tuberculosis Treatment Market Size (2015-2020)
6.2 Tuberculosis Treatment Key Players in North America (2019-2020)
6.3 North America Tuberculosis Treatment Market Size by Type (2015-2020)
6.4 North America Tuberculosis Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Tuberculosis Treatment Market Size (2015-2020)
7.2 Tuberculosis Treatment Key Players in Europe (2019-2020)
7.3 Europe Tuberculosis Treatment Market Size by Type (2015-2020)
7.4 Europe Tuberculosis Treatment Market Size by Application (2015-2020)
8 China
8.1 China Tuberculosis Treatment Market Size (2015-2020)
8.2 Tuberculosis Treatment Key Players in China (2019-2020)
8.3 China Tuberculosis Treatment Market Size by Type (2015-2020)
8.4 China Tuberculosis Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Tuberculosis Treatment Market Size (2015-2020)
9.2 Tuberculosis Treatment Key Players in Japan (2019-2020)
9.3 Japan Tuberculosis Treatment Market Size by Type (2015-2020)
9.4 Japan Tuberculosis Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Tuberculosis Treatment Market Size (2015-2020)
10.2 Tuberculosis Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Tuberculosis Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Tuberculosis Treatment Market Size by Application (2015-2020)
11 India
11.1 India Tuberculosis Treatment Market Size (2015-2020)
11.2 Tuberculosis Treatment Key Players in India (2019-2020)
11.3 India Tuberculosis Treatment Market Size by Type (2015-2020)
11.4 India Tuberculosis Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Tuberculosis Treatment Market Size (2015-2020)
12.2 Tuberculosis Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Tuberculosis Treatment Market Size by Type (2015-2020)
12.4 Central & South America Tuberculosis Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Tuberculosis Treatment Introduction
13.1.4 Sanofi Revenue in Tuberculosis Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Bayer
13.2.1 Bayer Company Details
13.2.2 Bayer Business Overview
13.2.3 Bayer Tuberculosis Treatment Introduction
13.2.4 Bayer Revenue in Tuberculosis Treatment Business (2015-2020)
13.2.5 Bayer Recent Development
13.3 Eli Lilly
13.3.1 Eli Lilly Company Details
13.3.2 Eli Lilly Business Overview
13.3.3 Eli Lilly Tuberculosis Treatment Introduction
13.3.4 Eli Lilly Revenue in Tuberculosis Treatment Business (2015-2020)
13.3.5 Eli Lilly Recent Development
13.4 Labatec Pharma
13.4.1 Labatec Pharma Company Details
13.4.2 Labatec Pharma Business Overview
13.4.3 Labatec Pharma Tuberculosis Treatment Introduction
13.4.4 Labatec Pharma Revenue in Tuberculosis Treatment Business (2015-2020)
13.4.5 Labatec Pharma Recent Development
13.5 Macleods Pharmaceuticals
13.5.1 Macleods Pharmaceuticals Company Details
13.5.2 Macleods Pharmaceuticals Business Overview
13.5.3 Macleods Pharmaceuticals Tuberculosis Treatment Introduction
13.5.4 Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2015-2020)
13.5.5 Macleods Pharmaceuticals Recent Development
13.6 Mylan
13.6.1 Mylan Company Details
13.6.2 Mylan Business Overview
13.6.3 Mylan Tuberculosis Treatment Introduction
13.6.4 Mylan Revenue in Tuberculosis Treatment Business (2015-2020)
13.6.5 Mylan Recent Development
13.7 Novatis
13.7.1 Novatis Company Details
13.7.2 Novatis Business Overview
13.7.3 Novatis Tuberculosis Treatment Introduction
13.7.4 Novatis Revenue in Tuberculosis Treatment Business (2015-2020)
13.7.5 Novatis Recent Development
13.8 Otsuka
13.8.1 Otsuka Company Details
13.8.2 Otsuka Business Overview
13.8.3 Otsuka Tuberculosis Treatment Introduction
13.8.4 Otsuka Revenue in Tuberculosis Treatment Business (2015-2020)
13.8.5 Otsuka Recent Development
13.9 Patheon
13.9.1 Patheon Company Details
13.9.2 Patheon Business Overview
13.9.3 Patheon Tuberculosis Treatment Introduction
13.9.4 Patheon Revenue in Tuberculosis Treatment Business (2015-2020)
13.9.5 Patheon Recent Development
13.10 Pfizer
13.10.1 Pfizer Company Details
13.10.2 Pfizer Business Overview
13.10.3 Pfizer Tuberculosis Treatment Introduction
13.10.4 Pfizer Revenue in Tuberculosis Treatment Business (2015-2020)
13.10.5 Pfizer Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Tuberculosis Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Tuberculosis Treatment Revenue
Table 3. Ranking of Global Top Tuberculosis Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Tuberculosis Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Active TB
Table 6. Key Players of Latent TB
Table 7. Global Tuberculosis Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 8. Global Tuberculosis Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 9. Global Tuberculosis Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 10. Global Tuberculosis Treatment Market Share by Regions (2015-2020)
Table 11. Global Tuberculosis Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 12. Global Tuberculosis Treatment Market Share by Regions (2021-2026)
Table 13. Market Top Trends
Table 14. Key Drivers: Impact Analysis
Table 15. Key Challenges
Table 16. Tuberculosis Treatment Market Growth Strategy
Table 17. Main Points Interviewed from Key Tuberculosis Treatment Players
Table 18. Global Tuberculosis Treatment Revenue by Players (2015-2020) (Million US$)
Table 19. Global Tuberculosis Treatment Market Share by Players (2015-2020)
Table 20. Global Top Tuberculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Treatment as of 2019)
Table 21. Global Tuberculosis Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Tuberculosis Treatment Product Solution and Service
Table 24. Date of Enter into Tuberculosis Treatment Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 27. Global Tuberculosis Treatment Market Size Share by Type (2015-2020)
Table 28. Global Tuberculosis Treatment Revenue Market Share by Type (2021-2026)
Table 29. Global Tuberculosis Treatment Market Size Share by Application (2015-2020)
Table 30. Global Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 31. Global Tuberculosis Treatment Market Size Share by Application (2021-2026)
Table 32. North America Key Players Tuberculosis Treatment Revenue (2019-2020) (Million US$)
Table 33. North America Key Players Tuberculosis Treatment Market Share (2019-2020)
Table 34. North America Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 35. North America Tuberculosis Treatment Market Share by Type (2015-2020)
Table 36. North America Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 37. North America Tuberculosis Treatment Market Share by Application (2015-2020)
Table 38. Europe Key Players Tuberculosis Treatment Revenue (2019-2020) (Million US$)
Table 39. Europe Key Players Tuberculosis Treatment Market Share (2019-2020)
Table 40. Europe Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 41. Europe Tuberculosis Treatment Market Share by Type (2015-2020)
Table 42. Europe Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 43. Europe Tuberculosis Treatment Market Share by Application (2015-2020)
Table 44. China Key Players Tuberculosis Treatment Revenue (2019-2020) (Million US$)
Table 45. China Key Players Tuberculosis Treatment Market Share (2019-2020)
Table 46. China Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 47. China Tuberculosis Treatment Market Share by Type (2015-2020)
Table 48. China Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 49. China Tuberculosis Treatment Market Share by Application (2015-2020)
Table 50. Japan Key Players Tuberculosis Treatment Revenue (2019-2020) (Million US$)
Table 51. Japan Key Players Tuberculosis Treatment Market Share (2019-2020)
Table 52. Japan Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 53. Japan Tuberculosis Treatment Market Share by Type (2015-2020)
Table 54. Japan Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 55. Japan Tuberculosis Treatment Market Share by Application (2015-2020)
Table 56. Southeast Asia Key Players Tuberculosis Treatment Revenue (2019-2020) (Million US$)
Table 57. Southeast Asia Key Players Tuberculosis Treatment Market Share (2019-2020)
Table 58. Southeast Asia Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 59. Southeast Asia Tuberculosis Treatment Market Share by Type (2015-2020)
Table 60. Southeast Asia Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 61. Southeast Asia Tuberculosis Treatment Market Share by Application (2015-2020)
Table 62. India Key Players Tuberculosis Treatment Revenue (2019-2020) (Million US$)
Table 63. India Key Players Tuberculosis Treatment Market Share (2019-2020)
Table 64. India Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 65. India Tuberculosis Treatment Market Share by Type (2015-2020)
Table 66. India Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 67. India Tuberculosis Treatment Market Share by Application (2015-2020)
Table 68. Central & South America Key Players Tuberculosis Treatment Revenue (2019-2020) (Million US$)
Table 69. Central & South America Key Players Tuberculosis Treatment Market Share (2019-2020)
Table 70. Central & South America Tuberculosis Treatment Market Size by Type (2015-2020) (Million US$)
Table 71. Central & South America Tuberculosis Treatment Market Share by Type (2015-2020)
Table 72. Central & South America Tuberculosis Treatment Market Size by Application (2015-2020) (Million US$)
Table 73. Central & South America Tuberculosis Treatment Market Share by Application (2015-2020)
Table 74. Sanofi Company Details
Table 75. Sanofi Business Overview
Table 76. Sanofi Product
Table 77. Sanofi Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 78. Sanofi Recent Development
Table 79. Bayer Company Details
Table 80. Bayer Business Overview
Table 81. Bayer Product
Table 82. Bayer Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 83. Bayer Recent Development
Table 84. Eli Lilly Company Details
Table 85. Eli Lilly Business Overview
Table 86. Eli Lilly Product
Table 87. Eli Lilly Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 88. Eli Lilly Recent Development
Table 89. Labatec Pharma Company Details
Table 90. Labatec Pharma Business Overview
Table 91. Labatec Pharma Product
Table 92. Labatec Pharma Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 93. Labatec Pharma Recent Development
Table 94. Macleods Pharmaceuticals Company Details
Table 95. Macleods Pharmaceuticals Business Overview
Table 96. Macleods Pharmaceuticals Product
Table 97. Macleods Pharmaceuticals Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 98. Macleods Pharmaceuticals Recent Development
Table 99. Mylan Company Details
Table 100. Mylan Business Overview
Table 101. Mylan Product
Table 102. Mylan Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 103. Mylan Recent Development
Table 104. Novatis Company Details
Table 105. Novatis Business Overview
Table 106. Novatis Product
Table 107. Novatis Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 108. Novatis Recent Development
Table 109. Otsuka Business Overview
Table 110. Otsuka Product
Table 111. Otsuka Company Details
Table 112. Otsuka Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 113. Otsuka Recent Development
Table 114. Patheon Company Details
Table 115. Patheon Business Overview
Table 116. Patheon Product
Table 117. Patheon Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 118. Patheon Recent Development
Table 119. Pfizer Company Details
Table 120. Pfizer Business Overview
Table 121. Pfizer Product
Table 122. Pfizer Revenue in Tuberculosis Treatment Business (2015-2020) (Million US$)
Table 123. Pfizer Recent Development
Table 124. Research Programs/Design for This Report
Table 125. Key Data Information from Secondary Sources
Table 126. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Tuberculosis Treatment Market Share by Type: 2020 VS 2026
Figure 2. Active TB Features
Figure 3. Latent TB Features
Figure 4. Global Tuberculosis Treatment Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Clinic Case Studies
Figure 7. Tuberculosis Treatment Report Years Considered
Figure 8. Global Tuberculosis Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Tuberculosis Treatment Market Share by Regions: 2020 VS 2026
Figure 10. Global Tuberculosis Treatment Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Tuberculosis Treatment Market Share by Players in 2019
Figure 13. Global Top Tuberculosis Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tuberculosis Treatment as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Tuberculosis Treatment Revenue in 2019
Figure 15. North America Tuberculosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Tuberculosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Tuberculosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Tuberculosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Tuberculosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Tuberculosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Tuberculosis Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Bottom-up and Top-down Approaches for This Report
Figure 23. Data Triangulation
Figure 24. Key Executives Interviewed
結核ワクチン治療の世界市場（～2026年） Tuberculosis (TB) is an infectious disease which is caused by the bacteria called Mycobacterium tuberculosis (MTB). Tuberculosis mainly affects lungs, but can also affect other parts of the body. Typical signs of tuberculosis includes chronic or persistent cough and sputum production. When TB is at …- 結核診断・治療の世界市場（～2026年） An infectious disease caused by the bacterium Mycobacterium tuberculosis (MTB) is known as Tuberculosis (TB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. The rising screening rate in the high burden regions, faster clinical decisions, and affordability of d…
- 結核治療薬の世界市場（～2026年） Tuberculosis (TB) is a disease caused by bacteria called Mycobacterium tuberculosis. The bacteria usually attack the lungs, but they can also damage other parts of the body. TB spreads through the air when a person with TB of the lungs or throat coughs, sneezes, or talks. Market Analysis and Insight…
- 結核（TB）診断の世界市場（～2026年） Tuberculosis (TB) is an infectious disease usually caused by the bacterium Mycobacterium tuberculosis (MTB). Tuberculosis generally affects the lungs, but can also affect other parts of the body. Most infections do not have symptoms, in which case it is known as latent tuberculosis. About 10% of lat…
- 抗結核治療薬の世界市場（～2026年） Tuberculosis (TB) is an infectious disease, which is caused by Mycobacterium tuberculosis. These bacteria generally infect human lungs. However, it can infect other body parts/organs as well. Three major types of tuberculosis are found: latent, active, and drug-resistant tuberculosis. Symptoms are n…